Universal Health Realty Income Trust Beheer

Beheer criteriumcontroles 4/4

De CEO Universal Health Realty Income Trust is Alan Miller, benoemd in Jan1986, heeft een ambtstermijn van 38.83 jaar. bezit rechtstreeks 1.18% van de aandelen van het bedrijf, ter waarde € 6.27M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 21.8 jaar en 6.9 jaar.

Belangrijke informatie

Alan Miller

Algemeen directeur

US$247.5k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	38.8yrs
Eigendom CEO	1.2%
Management gemiddelde ambtstermijn	21.8yrs
Gemiddelde ambtstermijn bestuur	6.9yrs

Recente managementupdates

Recent updates

CEO

Alan Miller (86 yo)

38.8yrs

Tenure

US$247,538

Compensatie

Mr. Alan B. Miller served as the Chief Executive Officer at Premier Behavioral Solutions, Inc. Mr. Miller has been the Chairman and Chief Executive Officer of Universal Health Realty Income Trust since 198...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Alan Miller	Chairman	38.8yrs	US$247.54k	1.18% € 6.3m
Charles Boyle	Senior VP & CFO	21.8yrs	US$143.94k	0.29% € 1.5m
Cheryl Ramagano	Senior VP of Operations	32.2yrs	US$143.94k	0.31% € 1.6m
Karla Peterson	Vice President of Acquisitions & Development	2.3yrs	US$62.99k	0.028% € 147.6k
Judith Romero	Vice President of Asset Management	2.4yrs	geen gegevens	geen gegevens
Genevieve Owsiany	VP & Controller	no data	geen gegevens	geen gegevens

21.8yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van WY8 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 21.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Alan Miller	Chairman	38.8yrs	US$247.54k	1.18% € 6.3m
Marc Miller	Trustee	15.9yrs	US$32.14k	0.046% € 244.2k
Robert McCadden	Lead Independent Trustee	10.9yrs	US$76.48k	0.090% € 475.5k
Michael Domb	Independent Trustee	6.9yrs	US$62.64k	0.083% € 441.1k
Gayle Capozzalo	Independent Trustee	6.7yrs	US$70.64k	0.025% € 135.0k
James Morey	Independent Trustee	6.3yrs	US$68.89k	0.023% € 119.7k
Rebecca Guzman	Independent Trustee	2yrs	US$61.48k	0.012% € 63.4k

6.9yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van WY8 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.9 jaar).

Universal Health Realty Income Trust Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Lead Independent Trustee recently bought €69k worth of stock

Chairman recently bought €195k worth of stock

Universal Health Realty Income Trust, Annual General Meeting, Jun 05, 2024

Chairman recently bought €94k worth of stock

Chairman recently bought €92k worth of stock

Insufficient new directors

Recent updates

Third quarter 2024 earnings released: EPS: US$0.29 (vs US$0.28 in 3Q 2023)

Second quarter dividend of US$0.73 announced

Universal Health Realty Income Trust Announces Dividend, Payable on September 30, 2024

Second quarter 2024 earnings released: EPS: US$0.38 (vs US$0.25 in 2Q 2023)

First quarter dividend of US$0.73 announced

Universal Health Realty Income Trust Announces Increased the Quarterly Dividend, Payable on June 28, 2024

Universal Health Realty Income Trust Votes to Increase the Quarterly Dividend, Payable on June 28, 2024

Lead Independent Trustee recently bought €69k worth of stock

Chairman recently bought €195k worth of stock

First quarter 2024 earnings released: EPS: US$0.38 (vs US$0.32 in 1Q 2023)

Universal Health Realty Income Trust, Annual General Meeting, Jun 05, 2024

Fourth quarter dividend of US$0.72 announced

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: US$1.12 (vs US$1.53 in FY 2022)

Now 24% undervalued

Investor sentiment improves as stock rises 17%

Universal Health Realty Income Trust Announces Quarterly Dividend, Payable on December 29, 2023

Third quarter 2023 earnings released: FFO per share: US$0.8 (vs US$0.86 in 3Q 2022)

Universal Health Realty Income Trust Announces Dividend, Payable on September 29, 2023

Now 21% undervalued

Second quarter 2023 earnings released: EPS: US$0.25 (vs US$0.38 in 2Q 2022)

Universal Health Realty Income Trust Announces Dividend Increase, Payable on June 30, 2023

Now 21% undervalued after recent price drop

Chairman recently bought €94k worth of stock

First quarter 2023 earnings released: FFO per share: US$0.8 (vs US$0.90 in 1Q 2022)

Chairman recently bought €92k worth of stock

Full year 2022 earnings released: EPS: US$1.53 (vs US$7.94 in FY 2021)

Now 21% undervalued

Upcoming dividend of US$0.71 per share

Universal Health Realty Income Trust Announces Quarterly Dividend Increase, Payable on December 30, 2022

Insufficient new directors

Third quarter 2022 earnings released: FFO per share: US$0.9 (vs US$0.92 in 3Q 2021)

Chairman recently bought €98k worth of stock

Universal Health Realty Income Trust Announces Dividend, Payable on September 30, 2022

Second quarter 2022 earnings released: FFO: US$22.5m per share (vs US$0.92 in 2Q 2021)

Universal Health Realty Income Trust(NYSE:UHT) dropped from Russell 2000 Value-Defensive Index

Universal Health Realty Income Trust Announces Dividend, Payable on June 30, 2022

Lead Independent Trustee recently bought €114k worth of stock

First quarter 2022 earnings released: FFO: US$22.4m per share (vs US$0.93 in 1Q 2021)

Insufficient new directors

Universal Health Realty Income Trust (NYSE:UHT) acquired Beaumont Heart and Vascular Center for $5.4 million.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Universal Health Realty Income Trust (NYSE:UHT) acquired 140 Thomas Johnson Drive for $8 million.

Upcoming dividend of US$0.70 per share

Third quarter 2021 earnings released: EPS US$0.39 (vs US$0.38 in 3Q 2020)

Independent Trustee recently bought €276k worth of stock

Chairman recently bought €220k worth of stock

Second quarter 2021 earnings released: FFO US$0.92 per share (vs US$0.83 in 2Q 2020)

Upcoming dividend of US$0.70 per share

Universal Health Realty Income Trust Increases Quarterly Dividend, Payable on June 30, 2021

First quarter 2021 earnings released: FFO US$0.93 per share (vs US$0.82 in 1Q 2020)

Upcoming Dividend of US$0.69 Per Share

New 90-day high: €60.00

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS US$1.42 (vs US$1.38 in FY 2019)

New 90-day high: €55.74

Third quarter 2020 earnings released: FFO US$0.86 per share

New 90-day low: €43.74

Third quarter earnings released

Independent Trustee recently bought €122k worth of stock

New 90-day low - €54.93

New 90-day low - €55.88

First half earnings released

New 90-day low - €56.79

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur